About HEMOGLOBIN OXYGEN THERAPEUTICS LLC
HbO2 Therapeutics is a leader in the development of hemoglobin-based oxygen carriers (HBOCs) for both human and veterinary use. The company has two core products: Hemopure and Oxyglobin, which are used to treat anemia and improve oxygen delivery in patients.
Development of hemoglobin-based oxygen carriers (HBOCs)Production of Hemopure and Oxyglobin for human and veterinary useResearch and clinical trials in oxygen delivery and anemia treatmentManufacturing of sterile, ready-to-use oxygen-carrying solutions
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| CANINE OXYGEN CARRIER MANUFACTURING RESTORATION AND REGULATORY ACTIVITIES | Department of Defense | $9.6M |
Is this your company?
Claim HEMOGLOBIN OXYGEN THERAPEUTICS LLC to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim HEMOGLOBIN OXYGEN THERAPEUTICS LLC & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.